Navigation Links
FDA Approves Cefepime for Use In B. Braun's DUPLEX(R) System
Date:5/11/2010

BETHLEHEM, Pa., May 11 /PRNewswire/ -- The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO )

Used in hospitals and healthcare centers to treat a wide variety of bacterial infections, Cefepime should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in the treatment of pneumonia, uncomplicated and complicated urinary tract infections, empiric therapy for febrile neutropenic patients, uncomplicated skin and skin structure infections, and complicated intra-abdominal infections. The availability of 1g and 2g Cefepime in the DUPLEX® System will mean faster, safer and accurate administration of Cefepime to patients as it can be stored ready-to-use in a container wherever and whenever it is needed.

"Making 1g and 2g Cefepime available to healthcare workers in B. Braun's DUPLEX® Drug Delivery System gives them another weapon to combat challenging infections with speed, safety and accuracy," said Rob Albert, Vice President of Marketing for B. Braun Medical Inc.

The DUPLEX® Drug Delivery System is a ready-to-use, two-compartment, flexible, eco-friendly IV container that stores pre-measured pharmaceuticals and diluent doses. DUPLEX® is easy to stock as it can be stored at room temperature, with 18-month minimum dating, and fits in automated medication dispensing systems. Unit dose-based DUPLEX® helps healthcare facilities achieve Joint Commission and USP Chapter < 797 > compliance that improves the practice of healthcare professionals while advancing patient safety.

Healthcare workers administering 1g or 2g Cefepime through DUPLEX® simply fold and squeeze the container and shake it to mix the pharmaceuticals and diluent. A barcode that references the final admixture, lot number and expiration date helps reduce medication errors, automate patient charting, track inventory and facilitate reimbursement tracking.

Customers interested in obtaining more information can call: 1-888-422-7286 (1-888-4BBRAUN).

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals.  For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
2. FDA Approves New Combination Product Oral Contraceptive
3. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
4. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
5. FDA Approves New Device for Adults with Severe and Persistent Asthma
6. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
7. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
8. FDA Approves First Totally Implanted Hearing System
9. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
10. FDA Approves Name Change for Heartburn Drug Kapidex
11. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... 2016 Research and Markets has announced ... in the USA"  report to their offering.  ,     (Logo: ... the current Positron Emission Tomography (PET) scanner and cyclotron ... market. Along with the current known number of PET ... , the report also contains a detailed breakdown of ...
(Date:5/5/2016)... 2016 Research and ... Thalassaemia Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights - 2016, provides comprehensive ... Thalassaemia market valuations and forecast, Thalassaemia products ...
(Date:5/4/2016)... for an upgrade. There are many medical recorders on the market but none like ... DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a renowned authorized reseller of ... technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... May 06, 2016 , ... The Price Agency in Birmingham, ... and assist the people of their local community. The agency pledges to select ... leaders. Their desire is to bring awareness to important local causes with fundraising ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... are scheduled to provide a unique keynote address at the 2016 Learning ... inspirational stories of five community college students. Their stories—of complicated family issues, financial ...
(Date:5/6/2016)... ... May 06, 2016 , ... Bluvault ( ... implementation service offering for global clients of Coupa ( Coupa Software ) and ... Integration Service is a key component in the suite of innovative implementation services ...
(Date:5/6/2016)... OR (PRWEB) , ... May 06, 2016 , ... Logically, ... In other seasons, when the weather is too cold, dry or hot, water on ... eyes can actually absorb moisture from the surrounding air. There’s only one problem, according ...
(Date:5/6/2016)... Atlanta (PRWEB) , ... May 06, 2016 , ... From ... provider Presence Technology will share its insights on managing Customers Engagement at ... , At SpeechTek 2016, Presence Technology will deliver a Presentation on “5 ...
Breaking Medicine News(10 mins):